These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25393958)

  • 21. Persistence of mutations during replication of an HIV library containing combinations of selected protease mutations.
    Song W; Maeda Y; Tenpaku A; Harada S; Yusa K
    Antiviral Res; 2004 Mar; 61(3):173-80. PubMed ID: 15168798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent inhibition of drug-resistant HIV protease variants by monoclonal antibodies.
    Bartonová V; Král V; Sieglová I; Brynda J; Fábry M; Horejsí M; Kozísek M; Sasková KG; Konvalinka J; Sedlácek J; Rezácová P
    Antiviral Res; 2008 Jun; 78(3):275-7. PubMed ID: 18329737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atazanavir signature I50L resistance substitution accounts for unique phenotype of increased susceptibility to other protease inhibitors in a variety of human immunodeficiency virus type 1 genetic backbones.
    Weinheimer S; Discotto L; Friborg J; Yang H; Colonno R
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3816-24. PubMed ID: 16127058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered replicative capacity of recombinant HIV type 1 containing mutations at codons 26 and 29 of the viral protease.
    Melón S; Gil-Roda C; de Oña M; Erice A
    AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1183-8. PubMed ID: 15588340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance to HIV protease inhibitors: a comparison of enzyme inhibition and antiviral potency.
    Klabe RM; Bacheler LT; Ala PJ; Erickson-Viitanen S; Meek JL
    Biochemistry; 1998 Jun; 37(24):8735-42. PubMed ID: 9628735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational patterns and correlated amino acid substitutions in the HIV-1 protease after virological failure to nelfinavir- and lopinavir/ritonavir-based treatments.
    Garriga C; Pérez-Elías MJ; Delgado R; Ruiz L; Nájera R; Pumarola T; Alonso-Socas Mdel M; García-Bujalance S; Menéndez-Arias L;
    J Med Virol; 2007 Nov; 79(11):1617-28. PubMed ID: 17854027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance to protease inhibitors.
    Kuritzkes DR
    J HIV Ther; 2002 Nov; 7(4):87-91. PubMed ID: 12733606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological recovery despite virological failure is independent of human immunodeficiency virus-type 1 resistant mutants in children receiving highly active antiretroviral therapy.
    Chiappini E; Galli L; Zazzi M; de Martino M
    J Med Virol; 2003 Aug; 70(4):506-12. PubMed ID: 12794711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection and Quantification of Label-Free Infectious Adenovirus Using a Switch-On Cell-Based Fluorescent Biosensor.
    Guerreiro MR; Freitas DF; Alves PM; Coroadinha AS
    ACS Sens; 2019 Jun; 4(6):1654-1661. PubMed ID: 31117363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HIV-1 Viral Protease Is Activated during Assembly and Budding Prior to Particle Release.
    Tabler CO; Wegman SJ; Chen J; Shroff H; Alhusaini N; Tilton JC
    J Virol; 2022 May; 96(9):e0219821. PubMed ID: 35438536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-time label-free measurement of HIV-1 protease activity by nanopore analysis.
    Wang L; Han Y; Zhou S; Guan X
    Biosens Bioelectron; 2014 Dec; 62():158-62. PubMed ID: 24997370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV protease-activated molecular switches based on beta-glucuronidase and alkaline phosphatase.
    O'Loughlin TL; Matsumura I
    Comb Chem High Throughput Screen; 2006 May; 9(4):313-20. PubMed ID: 16724922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational design of p53, an intrinsically unstructured protein, for the fabrication of novel molecular sensors.
    Geddie ML; O'Loughlin TL; Woods KK; Matsumura I
    J Biol Chem; 2005 Oct; 280(42):35641-6. PubMed ID: 16118206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanopore detects γ-radiation inhibited HIV-1 protease activity.
    Li M; Li W; Xiao Y; Liu Q; Liang L; Wang D; Huang W; Wang L
    Biosens Bioelectron; 2021 Dec; 194():113602. PubMed ID: 34481241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolutionary cell biology: two origins, one objective.
    Lynch M; Field MC; Goodson HV; Malik HS; Pereira-Leal JB; Roos DS; Turkewitz AP; Sazer S
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):16990-4. PubMed ID: 25404324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic biology. Genomically encoded analog memory with precise in vivo DNA writing in living cell populations.
    Farzadfard F; Lu TK
    Science; 2014 Nov; 346(6211):1256272. PubMed ID: 25395541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Web-based software tool for constraint-based design specification of synthetic biological systems.
    Oberortner E; Densmore D
    ACS Synth Biol; 2015 Jun; 4(6):757-60. PubMed ID: 25426642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and mechanical characterisation of giant unilamellar vesicles by a microfluidic method.
    Karamdad K; Law RV; Seddon JM; Brooks NJ; Ces O
    Lab Chip; 2015 Jan; 15(2):557-62. PubMed ID: 25413588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bugs.
    Hastings Cent Rep; 2014; 44(6):2. PubMed ID: 25412965
    [No Abstract]   [Full Text] [Related]  

  • 40. Reducing the genetic code induces massive rearrangement of the proteome.
    O'Donoghue P; Prat L; Kucklick M; Schäfer JG; Riedel K; Rinehart J; Söll D; Heinemann IU
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17206-11. PubMed ID: 25404328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.